According to the research report titled ‘Home Sleep Apnea Testing Devices Market Size By Portability (Portable Devices, Stationary Devices), By Structure (Wired Devices, Non-wired Devices), By Device Type (Type 1, Type 2, Type 3, Type 4), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Belgium, Greece, Netherlands, Norway, Portugal, Romania, Russia, Sweden, Turkey, Switzerland, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report, global home sleep apnea testing devices market is expected to surpass USD 1.4 billion in valuation by the year 2025.
 

Increased pervasiveness of sleep apnea disorders coupled with rising number of sleep centers are some of the major factors driving global home sleep apnea testing devices market. Large number of untreated patient population in tandem with supportive reimbursement policies are also aiding towards the market expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2361914/
 

Technological developments have resulted in development of affordable home sleep apnea tests that further has helped increased patient convenience and comfort, which in turn is stimulating the overall industry outlook.
 

In terms of portability, the report cites that the portable devices segment accounted for 80% market share in 2018 and is likely to showcase consistent growth throughout the estimated timeframe. Portable sleep apnea devices offer better performance, reduced time, easy handling, minimum cleaning, and reliability among both healthcare professionals as well as patients.
 

As per structure type, global home sleep apnea testing devices industry size from the non-wired devices segment is predicted to expand at 14.5% CAGR through 2025. Such devices are known to provide high convenience, easy handling, and are relatively affordable, thereby favoring the overall market scenario.
 

Moving on to device type, the report claims that the type 3 segment generated revenues worth USD 310 million in 2018 and is expected to record continuous growth throughout the study period. Type 3 sleep apnea devices provide better efficiency and affordability while diagnosing obstructive sleep apnea, and hence are witnessing high demand around the world.
 

Considering the geographical landscape, global home sleep apnea testing devices industry size in Canada is likely to witness 19% CAGR during 2019-2025. Increasing number of patients with sleep disorders, high undiagnosed population, and rising cognizance are facilitating the business scenario in Canada.
 

The competitive landscape of global home sleep apnea testing devices industry is defined by companies such as SOMNOmedics GmbH, SleepMed Inc., ResMed Corp., Nox Medical, Neurovirtual Sleepvirtual, Neurosoft S.A., Natus Medical Inc., Koninklijke Philips N.V., Itamar Medical Ltd., Contec Medical Systems Co. Ltd., Compumedics Limited, CleveMed, and Cadwell Laboratories Inc. among others.